Published in Am J Physiol Lung Cell Mol Physiol on December 27, 2013
The Extracellular Matrix in Bronchopulmonary Dysplasia: Target and Source. Front Med (Lausanne) (2015) 0.81
Microvessel mechanobiology in pulmonary arterial hypertension: cause and effect. Hypertension (2014) 0.78
Role of hypoxia-induced transglutaminase 2 in pulmonary artery smooth muscle cell proliferation. Am J Physiol Lung Cell Mol Physiol (2014) 0.78
Tissue transglutaminase promotes serotonin-induced AKT signaling and mitogenesis in pulmonary vascular smooth muscle cells. Cell Signal (2014) 0.77
Emerging concepts in smooth muscle contributions to airway structure and function: implications for health and disease. Am J Physiol Lung Cell Mol Physiol (2016) 0.75
Transglutaminase is a Critical Link Between Inflammation and Hypertension. J Am Heart Assoc (2016) 0.75
Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. N Engl J Med (1996) 11.76
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev (1994) 7.11
Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol (2000) 6.49
Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol (2003) 6.05
The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology (2007) 4.58
Transglutaminases: nature's biological glues. Biochem J (2002) 3.42
Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol (2000) 2.86
Cloning and expression of a functional serotonin transporter from rat brain. Nature (1991) 2.86
Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest (2001) 2.59
Transglutaminase 2 undergoes a large conformational change upon activation. PLoS Biol (2007) 2.53
Serotonin receptors. Chem Rev (2008) 2.43
Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation. PLoS Biol (2009) 2.40
Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. Cell (2003) 2.28
A unique central tryptophan hydroxylase isoform. Biochem Pharmacol (2003) 2.23
Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension. Circ Res (2006) 2.10
Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis. Ann Fam Med (2005) 2.03
Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension. Circ Res (2004) 1.92
PDGF stimulates pulmonary vascular smooth muscle cell proliferation by upregulating TRPC6 expression. Am J Physiol Cell Physiol (2003) 1.91
Increased plasma serotonin in primary pulmonary hypertension. Am J Med (1995) 1.86
Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice. Circ Res (2006) 1.85
Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J Clin Invest (2000) 1.80
Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia. Circulation (2006) 1.79
Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury. PLoS One (2008) 1.67
Serum vasoconstrictor, serotonin; isolation and characterization. J Biol Chem (1948) 1.66
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nat Med (2002) 1.65
Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease. Am J Pathol (1997) 1.64
Transglutaminase 2 inhibitors and their therapeutic role in disease states. Pharmacol Ther (2007) 1.60
Identification of a guanosine triphosphate-binding site on guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity. J Biol Chem (1987) 1.58
Contribution of the 5-HT(1B) receptor to hypoxia-induced pulmonary hypertension: converging evidence using 5-HT(1B)-receptor knockout mice and the 5-HT(1B/1D)-receptor antagonist GR127935. Circ Res (2001) 1.49
Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications. Amino Acids (2008) 1.47
Modulation of the in situ activity of tissue transglutaminase by calcium and GTP. J Biol Chem (1998) 1.45
A new role for an old molecule: serotonin as a mitogen. Am J Physiol (1997) 1.45
5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension. Br J Pharmacol (2000) 1.42
Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension. Circulation (1999) 1.42
Serotonin and blood pressure regulation. Pharmacol Rev (2012) 1.41
Rho kinase-induced nuclear translocation of ERK1/ERK2 in smooth muscle cell mitogenesis caused by serotonin. Circ Res (2004) 1.40
Extracellular TG2: emerging functions and regulation. FEBS J (2011) 1.35
Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease. Circulation (2003) 1.34
RhoA and Rho kinase activation in human pulmonary hypertension: role of 5-HT signaling. Am J Respir Crit Care Med (2009) 1.28
Transglutaminase-dependent RhoA activation and depletion by serotonin in vascular smooth muscle cells. J Biol Chem (2006) 1.27
Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells. Oncogene (2009) 1.25
Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice. J Exp Med (2011) 1.23
Unconventional secretion of tissue transglutaminase involves phospholipid-dependent delivery into recycling endosomes. PLoS One (2011) 1.22
Serotonin stimulates mitogen-activated protein kinase activity through the formation of superoxide anion. Am J Physiol (1999) 1.22
Transglutaminase 2: a multi-functional protein in multiple subcellular compartments. Amino Acids (2010) 1.20
Complexation of fibronectin with tissue transglutaminase. Biochemistry (1989) 1.16
Serotonylation of vascular proteins important to contraction. PLoS One (2009) 1.14
Effect of tryptophan hydroxylase 1 deficiency on the development of hypoxia-induced pulmonary hypertension. Hypertension (2006) 1.12
Measurement of tissue transglutaminase activity in a permeabilized cell system: its regulation by Ca2+ and nucleotides. Biochem J (1996) 1.11
Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1α. Am J Respir Crit Care Med (2014) 1.11
Pulmonary hypertension, anorexigens and 5-HT: pharmacological synergism in action? Trends Pharmacol Sci (1999) 1.10
The 5-HT transporter transactivates the PDGFbeta receptor in pulmonary artery smooth muscle cells. FASEB J (2007) 1.09
Roles of transglutaminases in cardiac and vascular diseases. Front Biosci (2007) 1.07
Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin. Am J Med (1990) 1.07
High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapy. Arterioscler Thromb Vasc Biol (2000) 1.07
Transglutaminase-mediated processing of fibronectin by endothelial cell monolayers. Biochemistry (1994) 1.05
Factors influencing the idiopathic development of pulmonary hypertension in the fawn hooded rat. Am Rev Respir Dis (1992) 1.04
Activation of extracellular transglutaminase 2 by thioredoxin. J Biol Chem (2011) 1.03
Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension. Respir Med (2009) 1.03
Role of protein transamidation in serotonin-induced proliferation and migration of pulmonary artery smooth muscle cells. Am J Respir Cell Mol Biol (2010) 1.01
H(2)O(2) signals 5-HT-induced ERK MAP kinase activation and mitogenesis of smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2001) 1.00
Cross-linking of plasma and cellular fibronectin by plasma transglutaminase. Ann N Y Acad Sci (1978) 0.99
Enhanced Ca(2+)-sensing receptor function in idiopathic pulmonary arterial hypertension. Circ Res (2012) 0.99
Increased tissue transglutaminase activity contributes to central vascular stiffness in eNOS knockout mice. Am J Physiol Heart Circ Physiol (2013) 0.98
TRPV4 channel contributes to serotonin-induced pulmonary vasoconstriction and the enhanced vascular reactivity in chronic hypoxic pulmonary hypertension. Am J Physiol Cell Physiol (2013) 0.97
Thrombospondin and fibrinogen bind serotonin-derivatized proteins on COAT-platelets. Blood (2002) 0.96
Dexfenfluramine as a mitogen signal via the formation of superoxide anion. FASEB J (2001) 0.95
Anti-inflammatory effects of the R2 peptide, an inhibitor of transglutaminase 2, in a mouse model of allergic asthma, induced by ovalbumin. Br J Pharmacol (2011) 0.95
Neural regulation of bone and the skeletal effects of serotonin (5-hydroxytryptamine). Mol Cell Endocrinol (2005) 0.94
Extracellular transglutaminase 2 has a role in cell adhesion, whereas intracellular transglutaminase 2 is involved in regulation of endothelial cell proliferation and apoptosis. Cell Prolif (2011) 0.93
New insights into the functions and localization of nuclear transglutaminase 2. FEBS J (2011) 0.92
Reactivity of the N-terminal region of fibronectin protein to transglutaminase 2 and factor XIIIA. J Biol Chem (2011) 0.92
The adenine nucleotide translocator 1 acts as a type 2 transglutaminase substrate: implications for mitochondrial-dependent apoptosis. Cell Death Differ (2009) 0.89
Alpha1B-adrenoceptor signaling and cell motility: GTPase function of Gh/transglutaminase 2 inhibits cell migration through interaction with cytoplasmic tail of integrin alpha subunits. J Biol Chem (2004) 0.89
Nitric oxide inhibits serotonin-induced calcium release in pulmonary artery smooth muscle cells. Am J Physiol (1997) 0.88
Novel roles for biogenic monoamines: from monoamines in transglutaminase-mediated post-translational protein modification to monoaminylation deregulation diseases. FEBS J (2011) 0.88
Evidence for a control of plasma serotonin levels by 5-hydroxytryptamine(2B) receptors in mice. J Pharmacol Exp Ther (2006) 0.87
Serotonin transporter interacts with the PDGFβ receptor in PDGF-BB-induced signaling and mitogenesis in pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2010) 0.86
Activation of in situ tissue transglutaminase by intracellular reactive oxygen species. Biochem Biophys Res Commun (2003) 0.86
Attenuation of the serotonin-induced increase in intracellular calcium in rat aortic smooth muscle cells by sarpogrelate. Can J Physiol Pharmacol (2003) 0.86
Nitric oxide regulates non-classical secretion of tissue transglutaminase. Commun Integr Biol (2011) 0.86
Serotonylated fibronectin is elevated in pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2012) 0.85
Serotonin increases the production of inositol phosphates and mobilises calcium via the 5-HT2 receptor in A7r5 smooth muscle cells. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.85
Elevated transglutaminase 2 activity is associated with hypoxia-induced experimental pulmonary hypertension in mice. ACS Chem Biol (2013) 0.85
Inhibition of gut- and lung-derived serotonin attenuates pulmonary hypertension in mice. Am J Physiol Lung Cell Mol Physiol (2012) 0.85
A Peptide with anti-transglutaminase activity decreases lipopolysaccharide-induced lung inflammation in mice. Exp Lung Res (2006) 0.84
Tissue transglutaminase promotes PDGF/PDGFR-mediated signaling and responses in vascular smooth muscle cells. J Cell Physiol (2012) 0.83
A role for the serotonin transporter in hypoxia-induced pulmonary hypertension. J Clin Invest (2000) 0.82
Dexfenfluramine increases pulmonary artery smooth muscle intracellular Ca2+, independent of membrane potential. Am J Physiol (1999) 0.82
Altered gene expression in pulmonary tissue of tryptophan hydroxylase-1 knockout mice: implications for pulmonary arterial hypertension. PLoS One (2011) 0.82
Transglutaminase-mediated transamidation of serotonin, dopamine and noradrenaline to fibronectin: evidence for a general mechanism of monoaminylation. FEBS Lett (2012) 0.82
Arachidonic acid activates tissue transglutaminase and stress fiber formation via intracellular reactive oxygen species. Biochem Biophys Res Commun (2004) 0.82
Gene therapy by targeted adenovirus-mediated knockdown of pulmonary endothelial Tph1 attenuates hypoxia-induced pulmonary hypertension. Mol Ther (2012) 0.81
Bone morphogenetic protein 2 decreases TRPC expression, store-operated Ca(2+) entry, and basal [Ca(2+)]i in rat distal pulmonary arterial smooth muscle cells. Am J Physiol Cell Physiol (2013) 0.81
Thioredoxin-1 mediates hypoxia-induced pulmonary artery smooth muscle cell proliferation. Am J Physiol Lung Cell Mol Physiol (2013) 0.81
Changes of fibronectin in the right and left ventricles of rats exposed to chronic normobaric hypoxia. Tohoku J Exp Med (1992) 0.81
Serotonin--more than a neurotransmitter: transglutaminase-mediated serotonylation of C6 glioma cells and fibronectin. Neurochem Int (2010) 0.81
Fluoxetine inhibits monocrotaline-induced pulmonary arterial remodeling involved in inhibition of RhoA-Rho kinase and Akt signalling pathways in rats. Can J Physiol Pharmacol (2012) 0.78
Effect of crosslinking by factor XIIIa on the migration of vascular smooth muscle cells into fibrin gels. Thromb Res (1998) 0.78
An in vivo tagging method reveals that Ras undergoes sustained activation upon transglutaminase-mediated protein serotonylation. Chembiochem (2013) 0.77
Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol (2000) 6.49
Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol (1998) 2.37
Regulation of cellular glutathione. Am J Physiol (1989) 2.26
Activation of an H2O2-generating NADH oxidase in human lung fibroblasts by transforming growth factor beta 1. J Biol Chem (1995) 2.13
Regulation of STAT3 by direct binding to the Rac1 GTPase. Science (2000) 1.77
Normobaric oxygen toxicity of the lung. N Engl J Med (1980) 1.56
Mechanical properties of rat cardiac muscle during experimental hypertrophy. Circ Res (1971) 1.48
Increased angiotensin-converting enzyme in peripheral blood monocytes from patients with sarcoidosis. J Clin Invest (1985) 1.38
Involvement of cell surface heparin sulfate in the binding of lipoprotein lipase to cultured bovine endothelial cells. J Clin Invest (1981) 1.38
Elevated serum angiotensin I converting enzyme in sarcoidosis. Am Rev Respir Dis (1976) 1.36
Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cells in culture. Circ Res (1991) 1.34
Serotonin stimulates mitogen-activated protein kinase activity through the formation of superoxide anion. Am J Physiol (1999) 1.22
Experimental cardiac hypertrophy. N Engl J Med (1970) 1.21
Regulation of endothelial cell xanthine dehydrogenase xanthine oxidase gene expression by oxygen tension. Am J Physiol (1994) 1.10
Serotonin produces both hyperplasia and hypertrophy of bovine pulmonary artery smooth muscle cells in culture. Am J Physiol (1994) 1.10
Transforming growth factor-beta 1-induced activation of the ERK pathway/activator protein-1 in human lung fibroblasts requires the autocrine induction of basic fibroblast growth factor. J Biol Chem (2000) 1.10
Endothelin 1: mitogenic activity on pulmonary artery smooth muscle cells and release from hypoxic endothelial cells. Proc Soc Exp Biol Med (1992) 1.08
Superoxide as an intermediate signal for serotonin-induced mitogenesis. Free Radic Biol Med (1998) 1.07
Coexistence of mucinous cystadenoma of the ovary and ovarian sarcoidosis. Am J Obstet Gynecol (1990) 1.05
Serotonin uptake by bovine pulmonary artery endothelial cells in culture. II. Stimulation by hypoxia. Am J Physiol (1986) 1.04
Pneumocystis carinii and cytomegalovirus pneumonia in a previously healthy adult. Am Rev Respir Dis (1982) 1.03
Ras-dependent and -independent regulation of reactive oxygen species by mitogenic growth factors and TGF-beta1. FASEB J (2000) 1.02
Glycolytic activity and enhancement of serotonin uptake by endothelial cells exposed to hypoxia/anoxia. Circ Res (1987) 1.02
Effects of hypoxia and hyperoxia on proteoglycan production by bovine pulmonary artery endothelial cells. J Cell Physiol (1986) 1.00
H(2)O(2) signals 5-HT-induced ERK MAP kinase activation and mitogenesis of smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2001) 1.00
Oxidative protein cross-linking reactions involving L-tyrosine in transforming growth factor-beta1-stimulated fibroblasts. J Biol Chem (2001) 1.00
Membrane-bound angiotensin-converting enzyme from rat lung. J Biol Chem (1974) 0.99
Tyrosine phosphorylation regulates H2O2 production in lung fibroblasts stimulated by transforming growth factor beta1. J Biol Chem (1998) 0.99
Angiotensin-converting enzyme from human tissues. Physicochemical, catalytic, and immunological properties. J Biol Chem (1985) 0.98
Endothelial cell damage after gamma-irradiation in vitro: impaired uptake of alpha-aminoisobutyric acid. Am Rev Respir Dis (1982) 0.97
Regulation of PDGF production and ERK activation by estrogen is associated with TSC2 gene expression. Am J Physiol Cell Physiol (2003) 0.95
Angiotensin I converting enzyme from human plasma. Biochemistry (1977) 0.95
Dexfenfluramine as a mitogen signal via the formation of superoxide anion. FASEB J (2001) 0.95
Upregulated expression of fibroblast growth factor (FGF) receptors by transforming growth factor-beta1 (TGF-beta1) mediates enhanced mitogenic responses to FGFs in cultured human lung fibroblasts. Biochem Biophys Res Commun (1998) 0.95
TGF-beta 1 produces a "prooxidant" effect on bovine pulmonary artery endothelial cells in culture. Am J Physiol (1991) 0.92
Serotonin uptake by bovine pulmonary artery endothelial cells in culture. I. Characterization. Am J Physiol (1986) 0.91
Calcium transport in isolated sarcoplasmic reticulum during muscle maturation. Nature (1968) 0.91
Prostaglandins and the lung. Am Rev Respir Dis (1973) 0.91
Angiotensin I-converting enzyme localization on cultured fibroblasts by immunofluorescence. In Vitro (1982) 0.90
Labeling of RNA in the perfused heart: the problem of bacterial contamination. Biochim Biophys Acta (1969) 0.89
Elevation of glutathione levels in bovine pulmonary artery endothelial cells by N-acetylcysteine. Am J Respir Cell Mol Biol (1992) 0.89
Increase in endothelial cell glutathione and precursor amino acid uptake by diethyl maleate and hyperoxia. Am J Physiol (1989) 0.89
Immunochemical comparison of angiotensin 1 converting enzymes from different rat organs. Int J Biochem (1979) 0.89
Myocardial glutathione depletion impairs recovery after short periods of ischemia. Circulation (1989) 0.88
Familial elevation of serum angiotensin converting enzyme. Q J Med (1985) 0.87
Chloride efflux in cyclic AMP-induced configurational change of bovine pulmonary artery endothelial cells. Circ Res (1990) 0.87
The effect of lathyrogen beta-amino proprionitrile (BAPN) on the mechanical properties of experimentally hypertrophied rat cardiac muscle. Circ Res (1978) 0.87
Enhanced rate of H2O2 release from bovine pulmonary artery endothelial cells induced by TGF-beta 1. Am J Physiol (1993) 0.86
Ribonucleic acid synthesis in experimental cardiac hypertrophy in rats. I. Characterization and kinetics of labeling. Circ Res (1968) 0.86
Serotonin uptake and configurational change of bovine pulmonary artery smooth muscle cells in culture. J Cell Physiol (1989) 0.86
Association of Tyr phosphorylation of GTPase-activating protein with mitogenic action of serotonin. Am J Physiol (1997) 0.86
Drug therapy reviews: treatment of sarcoidosis. Am J Hosp Pharm (1979) 0.85
Regulation of serotonin-induced DNA synthesis of bovine pulmonary artery smooth muscle cells. Am J Physiol (1994) 0.85
Influence of exogenously generated oxidant species on myocardial function. Am J Physiol (1986) 0.85
Stimulation of bovine pulmonary artery endothelial cell ACE by dexamethasone: involvement of steroid receptors. Am J Physiol (1992) 0.85
The effect of oxygen tension on the in vitro production and release of angiotensin-converting enzyme by bovine pulmonary artery endothelial cells. Am Rev Respir Dis (1984) 0.85
Bleomycin upregulates gene expression of angiotensin-converting enzyme via mitogen-activated protein kinase and early growth response 1 transcription factor. Am J Respir Cell Mol Biol (2001) 0.84
Angiotensin-converting enzyme in bronchoalveolar lining fluid. Lancet (1979) 0.84
Development of competitive enzyme immunoassays for human serum angiotensin-1-converting enzyme: a comparison of four assay configurations. Anal Biochem (1982) 0.84
Transient depletion of lung glutathione by diethylmaleate enhances oxygen toxicity. J Appl Physiol (1985) (1985) 0.84
Ribonucleic acid synthesis in experimental cardiac hypertrophy in rats. II. Aspects of regulation. Circ Res (1968) 0.83
Potentiation of oxygen toxicity in rats by dietary protein or amino acid deficiency. J Appl Physiol Respir Environ Exerc Physiol (1983) 0.83
Effect of hyperoxia on glutathione levels and glutamic acid uptake in endothelial cells. J Appl Physiol (1985) (1987) 0.83
Reduction of glutathione is associated with growth restriction and enlargement of bovine pulmonary artery endothelial cells produced by transforming growth factor-beta 1. Am J Respir Cell Mol Biol (1992) 0.82
Oxygen toxicity of the lung: an update. Br J Anaesth (1982) 0.82
Angiotensin-1-converting enzyme (ACE) activity in human serum following plasma exchange. Proc Soc Exp Biol Med (1983) 0.82
Enhancement by disulfiram (Antabuse) of toxic effects of 95 to 97% O2 on the rat lung. J Pharmacol Exp Ther (1979) 0.82
Serotonin produces a configurational change of cultured smooth muscle cells that is associated with elevation of intracellular cAMP. J Cell Physiol (1992) 0.81
Elevation of bovine endothelial cell angiotensin converting enzyme by cationophores and inhibition by ouabain. Biochim Biophys Acta (1990) 0.81
Involvement of glutathione enzymes in O2 tolerance development by diethyldithiocarbamate. Biochem Pharmacol (1980) 0.81
Calcium transport by skeletal muscle sarcoplasmic reticulum in the hypothyroid rat. J Clin Invest (1969) 0.81
Phospholipase D signaling in serotonin-induced mitogenesis of pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2008) 0.81
Angiotensin-1-converting enzyme activity in the spontaneously hypertensive rat. Proc Soc Exp Biol Med (1980) 0.81
Prostaglandins E1 and E2 stimulate the proliferation of pulmonary artery smooth muscle cells. Prostaglandins (1992) 0.80
Mechanism of basal and transforming growth factor beta 1 stimulated H2O2 release by endothelial cells. Trans Assoc Am Physicians (1993) 0.80
Elevation of angiotensin converting enzyme by 3-isobutyl-1-methylxanthine in cultured endothelial cells: a possible role for calmodulin. J Cell Physiol (1988) 0.80
Lung angiotensin converting enzyme activity in rats with differing susceptibilities to chronic hypoxia. Thorax (1988) 0.80
Stimulation of bovine endothelial cell angiotensin-I-converting enzyme activity by cyclic AMP-related agents. J Cell Physiol (1986) 0.80
Conversion of angiotensin 1 to angiotensin 2 in the isolated perfused dog lung. J Appl Physiol (1973) 0.80
Hormonal influence on endothelial cell angiotensin-converting enzyme activity. Am J Physiol (1984) 0.79
Regulation of Cu,Zn-superoxide dismutase in bovine pulmonary artery endothelial cells. J Cell Physiol (1992) 0.79
Effect of bleomycin on collagenolytic activity of the rat alveolar macrophage. Am Rev Respir Dis (1980) 0.79
Angiotensin-1-converting enzyme activity of murine macrophages isolated from granulomas elicited by eggs of Schistosoma mansoni. Infect Immun (1983) 0.79
Modulation of transforming growth factor-beta 1 antiproliferative effects on endothelial cells by cysteine, cystine, and N-acetylcysteine. J Clin Invest (1992) 0.79
Elevation of angiotensin converting enzyme in bovine endothelial cells quantitated by an ELISA. Life Sci (1990) 0.79
Pyrimidine nucleotide synthesis in the normal and hypertrophying rat heart. Relative importance of the de novo and "salvage" pathways. Circ Res (1970) 0.79
Cu,Zn superoxide dismutase in vascular cells: changes during cell cycling and exposure to hyperoxia. Am J Physiol (1993) 0.79
Relative quantification of angiotensin-converting enzyme mRNA in human smooth muscle cells, monocytes, and lymphocytes by the polymerase chain reaction. Anal Biochem (1994) 0.78
Angiotensin converting enzyme (kininase II) mRNA production and enzymatic activity in human peripheral blood monocytes are induced by GM-CSF but not by other cytokines. Biochim Biophys Acta (1994) 0.78
Inhibition of pulmonary artery smooth muscle cell growth by hypoxanthine, xanthine, and uric acid. Am J Respir Cell Mol Biol (1992) 0.78
Endothelial cell inhibition of hypoxia-induced stimulation of serotonin uptake by vascular smooth muscle cells. Am Rev Respir Dis (1989) 0.78
Nitric oxide increases cellular glutathione levels in rat lung fibroblasts. Am J Respir Cell Mol Biol (1995) 0.78
Heart growth in response to aortic constriction in the hypophysectomized rat. Am J Physiol (1970) 0.78
8-hydroxy-2-(di-n-propylamino)tetralin-responsive 5-hydroxytryptamine4-like receptor expressed in bovine pulmonary artery smooth muscle cells. Mol Pharmacol (1992) 0.78
Ultrastructural changes in bovine pulmonary artery endothelial cells exposed to 80% O2 in vitro. In Vitro (1983) 0.78
Reduction of endothelial cell related TGFbeta activity by thiols. Endothelium (1999) 0.78
Plasma antioxidants in subjects before hematopoietic stem cell transplantation. Bone Marrow Transplant (2006) 0.78
Conversion of angiotensin-1 to angiotensin-2 by a latent endothelial cell peptidyl dipeptidase that is not angiotensin-converting enzyme. Biochem Biophys Res Commun (1986) 0.78
Metastatic endotracheal tumor from ovarian carcinoma. Chest (1980) 0.77
Characterization of glutamic acid uptake by bovine pulmonary arterial endothelial cells. J Appl Physiol (1985) (1987) 0.77